Xanthoderma: A clinical review

Journal of the American Academy of Dermatology

Volumn 57, Issue 6, 2007, Pages 1051-1058

  Haught, Justin M ^a   Patel, Shaily ^a   English III, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHAXANTHIN; CHLORPROMAZINE; ORAL CONTRACEPTIVE AGENT; PROBENECID; RIFAMPICIN; TETRACYCLINE;

ALGORITHM; APLASTIC ANEMIA; CAROTENODERMA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HEPATITIS; HUMAN; JAUNDICE; NAIL DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SKIN DISCOLORATION; URTICARIA; XANTHODERMA; XANTHONYCHIA;

CAROTENOIDS; HUMANS; JAUNDICE; PIGMENTATION DISORDERS;

EID: 36049017657     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.011     Document Type: Review

References (50)

1. Alaluf S., Atkins D., Barrett K., Blount M., Carter N., and Heath A. The impact of epidermal melanin on objective measurements of human skin color. Pigment Cell Res 15 (2002) 119-126
2. Pratt D.S., and Kaplan M.M. Jaundice. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., Jameson J.L., et al. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 238-243 611-2
3. Leonard J.W. Carotenemia vs jaundice. JAMA 236 (1976) 2603
4. Kuiper J.J. Conjunctival icterus. Ann Intern Med 134 (2001) 345-346
5. Stoll B.J., and Kliegman R.M. Jaundice and hyperbilirubinemia in the newborn. In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson textbook of pediatrics. 17th ed. (2004), WB Saunders, Philadelphia
6. Maharshak N., Shapiro J., and Trau H. Carotenoderma-a review of the current literature. Int J Dermatol 42 (2003) 178-181
7. Chaparro R.S., Carr E., and Barron J.L. Hypercarotenemia or hypercarotenoidemia. Ann Clin Biochem 40 (2003) 280-282
8. Ford E.S., Gillespie C., Ballew C., Sowell A., and Mannino D.M. Serum carotenoid concentrations in US children and adolescents. Am J Clin Nutr 76 (2002) 818-827
9. Ford E.S. Variations in serum carotenoid concentrations among United States adults by ethnicity and sex. Ethn Dis 10 (2000) 208-217
10. Parker R.S. Absorption, metabolism, and transport of carotenoids. FASEB J 10 (1996) 542-551
11. Alaluf S., Heinrich U., Stahl W., Tronnier H., and Wiseman S. Dietary carotenoids contribute to normal human skin color and UV photosensitivity. J Nutr 132 (2002) 399-403
12. al-Jubouri M.A., Coombes E.J., Young R.M., and McLaughlin N.P. Xanthoderma: an unusual presentation of hypothyroidism. J Clin Pathol 47 (1994) 850-851
13. Stack K.M., Churchwell M.A., and Skinner R.B. Xanthoderma: case report and differential diagnosis. Cutis 41 (1988) 100-102
14. Reich P., Shwachman H., and Craig J.M. Lycopenemia: a variant of carotenemia. N Engl J Med 262 (1960) 263-269
15. La Placa M., Pazzaglia M., and Tosti A. Lycopenemia. J Eur Acad Dermatol Venereol 14 (2000) 311-312
16. Takita Y., Ichimiya M., Hamamoto Y., and Muto M. A case of carotenemia associated with ingestion of nutrient supplements. J Dermatol 33 (2006) 132-134
17. Roe D.A. Assessment of risk factors for carotenoderma and cutaneous signs of hypervitaminosis A in college-aged populations. Semin Dermatol 10 (1991) 303-308
18. Hoerer E., Dreyfuss F., and Herzberg M. Carotenemic skin color and diabetes mellitus. Acta Diabetol Lat 12 (1975) 202-207
19. Leung A.K. Carotenemia. Adv Pediatr 34 (1987) 223-248
20. Lieber C.S. Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic disease. Mt Sinai J Med 67 (2000) 84-94
21. Pops M.A., and Schwabe A.D. Hypercarotenemia in anorexia nervosa. JAMA 205 (1968) 533-534
22. Boland B., Bequin C., Zech F., Desager J.P., and Lambert M. Serum beta-carotene in anorexia nervosa patients: a case-control study. Int J Eat Disord 30 (2001) 299-305
23. Gupta M.A., Gupta A.K., and Haberman H.F. Dermatologic signs in anorexia nervosa and bulimia nervosa. Arch Dermatol 123 (1987) 1386-1390
24. Singh S., Mulley G.P., and Losowsky M.S. Carotenemia in Alzheimer's disease. BMJ 297 (1988) 458-459
25. Jimenez-Jimenez F.J., Molina J.A., de Bustos F., Ortí-Pareja M., Benito-León J., Tallón-Barranco A., et al. Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol 6 (1999) 495-497
26. Svensson A., and Vahlquist A. Metabolic carotenemia and carotenoderma in a child. Acta Derm Venereol 75 (1995) 70-71
27. Canthaxanthin-your questions answered. Available from: URL: http://www.food.gov.uk/multimedia/webpage/canthaxanthin_qanda/. Accessed November 18, 2006.
28. Meadows M. Don't be in the dark about tanning. FDA Consum 37 (2003) 16-17
29. Bluhm R., Branch R., Johnston P., and Stein R. Aplastic anemia associated with canthaxanthin ingested for "tanning" purposes. JAMA 264 (1990) 1141-1142
30. Gjerlow J. Granulocytopenia as a sequel to carotenemia: a case with cutaneous xanthosis as a sequel to long-term excessive consumption of carrots. Tidsskr Nor Laegeforen 86 (1966) 33-34
31. Nishimura T. A correlation between carotenemia and biliary dyskinesia. J Dermatol 20 (1993) 287-292
32. Mathews-Roth M.M. Amenorrhea associated with carotenemia. JAMA 250 (1983) 731
33. Palleschi G.M., Knoepfel B.R., and Lotti T. Carotenoderma: a possible pit-fall in the immunopathologic diagnosis of pemphigus vulgaris. Int J Dermatol 31 (1992) 50-51
34. Farhangi M., and Osserman E.F. Myeloma with xanthoderma due to an IgG lambda monoclonal anti-flavin antibody. N Engl J Med 294 (1976) 177-183
35. Merlini G., Bruening R., Kyle R.A., and Osserman E.F. The second riboflavin-binding myeloma IgG lambda DOT.I. Biochemical and functional characterization. Mol Immunol 27 (1990) 385-394
36. Wolff K., Johnson R.A., and Suurmond D. Drug-induced pigmentation. In: Wolff K., Johnson R.A., and Suurmond D. (Eds). Fitzpatrick's color atlas and synopsis of clinical dermatology. 5th ed. (2005), McGraw-Hill, New York 562-564
37. Sokol R.J., Lichtenstein P.K., and Farrell M.K. Quinacrine hydrochloride-induced yellow discoloration of the skin in children. Pediatrics 69 (1982) 232-233
38. Perez E. "Carbolic acid." Medline Plus, March 21, 2006. US National Library of Medicine and the National Institutes of Health, Bethesda, MD. Available from: URL:http://www.nlm.nih.gov/medlineplus/ency/article/002890.htm. Accessed November 4, 2006.
39. Cohen S.R. Yellow staining caused by 4,4'-methylenedianiline exposure: occurrence among molded plastics workers. Arch Dermatol 121 (1985) 1022-1027
40. Personne M., Mansten A., and Svansson J.O. A case report: unconscious patient with neon yellow skin was intoxicated with dipyridamole. Lakartidningen 100 (2003) 4194-4195
41. Fu J.M., Dusza S.W., and Halpern A.C. Sunless tanning. J Am Acad Dermatol 50 (2004) 706-713
42. James W.D., Berger T.G., and Elston D.M. Xanthoma planum. In: James W.D., Berger T.G., and Elston D.M. (Eds). Andrews' diseases of the skin: clinical dermatology. 10th ed. (2006), WB Saunders, Philadelphia 531-532
43. Cohen P.R. The lunula. J Am Acad Dermatol 34 (1996) 943-953
44. Verghese A., Krish G., Howe D., and Stonecipher M. The harlequin nail: a marker for smoking cessation. Chest 97 (1990) 236-238
45. James W.D., Berger T.G., and Elston D.M. Psoriasis. In: James W.D., Berger T.G., and Elston D.M. (Eds). Andrews' diseases of the skin: clinical dermatology. 10th ed. (2006), WB Saunders, Philadelphia 193
46. James W.D., Berger T.G., and Elston D.M. Yellow nail syndrome. In: James W.D., Berger T.G., and Elston D.M. (Eds). Andrews' diseases of the skin: clinical dermatology. 10th ed. (2006), WB Saunders, Philadelphia 792
47. Pavlidakey G.P., Hashimoto K., and Blum D. Yellow nail syndrome. J Am Acad Dermatol 11 (1984) 509-512
48. Kellen R.I., Schrank B., and Burde R.M. Yellow forelock-a new neuro-ophthalmological sign. Br J Ophthalmol 74 (1990) 509-510
49. Rogers M.J., Whitefield M., and Marks V.J. Yellow hair discoloration due to anthralin. J Am Acad Dermatol 19 (1988) 370-371
50. Sale T.A., and Stratman E. Carotenemia associated with green bean ingestion. Pediatr Dermatol 21 (2004) 657-659